| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/30/2001 | WO2001063293A2 Diagnosis and treatment of schizophrenia |
| 08/30/2001 | WO2001063281A1 Methods of screening for compounds that modulate blood vessel formation |
| 08/30/2001 | WO2001063280A2 Inter-alpha-trypsin as a marker for sepsis |
| 08/30/2001 | WO2001063279A2 Method of identifying toxic agents using differential gene expression |
| 08/30/2001 | WO2001062973A1 Antisense modulation of e2f transcription factor 3 expression |
| 08/30/2001 | WO2001062972A1 Methods for identifying candidate polynucleotide molecules encoding a protease |
| 08/30/2001 | WO2001062942A2 MATERIALS AND METHODS INVOLVING HYBRID VASCULAR ENDOTHELIAL GROWTH FACTOR DNAs AND PROTEINS AND SCREENING METHODS FOR MODULATORS |
| 08/30/2001 | WO2001062940A2 New phosphodiesterase type 7b |
| 08/30/2001 | WO2001062937A1 Skin infection-related retroviral sequences |
| 08/30/2001 | WO2001062936A2 Bunyaviridal reaper proteins and uses therefor |
| 08/30/2001 | WO2001062933A2 Muteins of interleukin-13 (il-13) |
| 08/30/2001 | WO2001062932A1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 08/30/2001 | WO2001062931A2 ANTI-EGFRvIII SCFVS WITH IMPROVED CYTOTOXICITY AND YIELD, IMMUNOTOXINS BASED THEREON, AND METHODS OF USE THEREOF |
| 08/30/2001 | WO2001062929A2 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 08/30/2001 | WO2001062928A2 Polypeptides and nucleic acids encoding same |
| 08/30/2001 | WO2001062927A2 Polypeptides and corresponding polynucleotides for diagnostics and therapeutics |
| 08/30/2001 | WO2001062924A2 Human g protein-coupled receptors |
| 08/30/2001 | WO2001062923A2 Transporters and ion channels |
| 08/30/2001 | WO2001062922A2 Polypeptides and corresponding molecules for disease detection and treatment |
| 08/30/2001 | WO2001062921A2 Novel human regulatory protein and polynucleotides encoding the same |
| 08/30/2001 | WO2001062920A2 Compositions and methods for diagnosis and therapy of malignant mesothelioma |
| 08/30/2001 | WO2001062918A2 Secretory polypeptides and corresponding polynucleotides |
| 08/30/2001 | WO2001062916A1 Novel armadillo repeat-containing protein alex1 |
| 08/30/2001 | WO2001062915A1 Novel protein and gene encoding the same |
| 08/30/2001 | WO2001062914A1 Bcmp 84, a protein associated to breast cancer |
| 08/30/2001 | WO2001062913A1 Vertebrate globin |
| 08/30/2001 | WO2001062912A2 Method of modulating glycosylation pathways |
| 08/30/2001 | WO2001062911A2 Antisense and catalytically acting nucleic acid molecules targeted to grb2- related with insert domain (grid) proteins and their uses |
| 08/30/2001 | WO2001062908A2 Chimeric and tcr phage display libraries, chimeric and tcr reagents and methods of use thereof |
| 08/30/2001 | WO2001062905A2 Integrin antagonists |
| 08/30/2001 | WO2001062893A2 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 08/30/2001 | WO2001062891A2 207 human secreted proteins |
| 08/30/2001 | WO2001062799A2 Method for inhibiting angiogenesis using molecules that enhance plasmin activity |
| 08/30/2001 | WO2001062797A2 G protein-coupled receptors |
| 08/30/2001 | WO2001062796A1 Ccr2-64i, polymorphic variant of the human ccrs receptor and its use in the diagnostic and treatment of atherosclerosis |
| 08/30/2001 | WO2001062795A1 COMPOUNDS RELATED TO OR DERIVED FROM GFRα4 AND THEIR USE |
| 08/30/2001 | WO2001062794A2 18607, a human calcium channel |
| 08/30/2001 | WO2001062792A2 Cancer treatment and prognosis involving hes-1 protein |
| 08/30/2001 | WO2001062791A2 Control of tgf (beta) signaling by km23 superfamily members |
| 08/30/2001 | WO2001062790A2 Nuclear factor polypeptides and nucleic acids encoding same |
| 08/30/2001 | WO2001062789A1 Human polynucleotides, polypeptides, and antibodies |
| 08/30/2001 | WO2001062788A2 Corneodesmosin based test and model for inflammatory disease |
| 08/30/2001 | WO2001062786A2 Tlp peptides and dna sequences coding the same |
| 08/30/2001 | WO2001062785A2 Protein and gene and their use for diagnosis and treatment of schizophrenia |
| 08/30/2001 | WO2001062784A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
| 08/30/2001 | WO2001062783A1 A novel polypeptide-human split complex 69 and the polynucleotide encoding said polypeptide |
| 08/30/2001 | WO2001062782A1 A novel polypeptide-arrestin family 11 and the polynucleotide encoding said polypeptide |
| 08/30/2001 | WO2001062778A2 Tumour-specific animal proteins |
| 08/30/2001 | WO2001062777A1 Bombesin analogs for treatment of cancer |
| 08/30/2001 | WO2001062776A1 Hla binding peptides and their uses |
| 08/30/2001 | WO2001062775A2 Novel antiarrhythmic peptides |
| 08/30/2001 | WO2001062774A2 Purified lh |
| 08/30/2001 | WO2001062773A1 PROCESS OF PURIFICATION OF hCG AND RECOMBINANT hCG PURIFIED BY THAT METHOD |
| 08/30/2001 | WO2001062770A1 Staphylococcal gtpase obgcleotide sequence encoding staphylococcal gtp-binding protein |
| 08/30/2001 | WO2001062767A1 IDENTIFICATION OF A cDNA ASSOCIATED WITH VENTRICULAR FUNCTION IN HUMAN MYOCARDIAL TISSUE |
| 08/30/2001 | WO2001062735A1 Novel malonic acid derivatives, processes for their preparation, their use as inhibitor of factor xa activity and pharmaceutical compositions containing them |
| 08/30/2001 | WO2001062725A2 Methods and compositions for inhibiting angiogenesis |
| 08/30/2001 | WO2001062300A2 Caspase activated prodrugs therapy |
| 08/30/2001 | WO2001062297A1 Compositions and methods for enhancing drug delivery across biological membranes and tissues |
| 08/30/2001 | WO2001062296A2 Non-aqueous injectable formulations for extended release of somatotropin |
| 08/30/2001 | WO2001062291A1 Compositions for preventing and treating digestive diseases |
| 08/30/2001 | WO2001062289A2 Photodynamic cellular and acellular organism eradication utilizing a photosensitive material and surfactant |
| 08/30/2001 | WO2001062288A1 Membrane estrogen receptor-directed therapy in breast cancer |
| 08/30/2001 | WO2001062287A1 Methods of prevention and treatment of asthma, and allergic conditions |
| 08/30/2001 | WO2001062285A1 Use of il-18 inhibitors |
| 08/30/2001 | WO2001062284A2 Novel method for down-regulation of amyloid |
| 08/30/2001 | WO2001062281A1 Pai-2 conjugates for the treatment and imaging of cancer |
| 08/30/2001 | WO2001062280A2 Lipase-containing composition and methods of use thereof |
| 08/30/2001 | WO2001062279A1 Method of treatment of anorectal disorders |
| 08/30/2001 | WO2001062278A1 Hemostatic soluble cellulose fibers containing coagulating protein for treating wound and process for producing the same |
| 08/30/2001 | WO2001062277A1 Treatment for peripheral sensory neuropathy |
| 08/30/2001 | WO2001062276A1 A stable composition comprising epidermal growth factor as an active ingredient |
| 08/30/2001 | WO2001062275A1 Adjuvant treatment by in vivo activation of dendritic cells |
| 08/30/2001 | WO2001062274A1 Combined use of chemokine ip-10 and interleukin 12 in the preparation of compositions for the treatment of malignant tumors |
| 08/30/2001 | WO2001062273A1 The use of gdnf family-related compounds for manufacturing products for treating testicular tumors |
| 08/30/2001 | WO2001062272A2 Soluble tumor necrosis factor receptor and il-4 inhibitor for the treatment of medical disorders |
| 08/30/2001 | WO2001062271A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/30/2001 | WO2001062270A2 Method for treating hashimoto's thyroiditis |
| 08/30/2001 | WO2001062269A2 Use of neurotoxins for treating parathyroid disorders |
| 08/30/2001 | WO2001062268A1 Endoparasiticidal agents |
| 08/30/2001 | WO2001062267A2 Oral gel containing sulfurated amino acid compounds |
| 08/30/2001 | WO2001062266A2 Use of dpp-iv inhibitors for the treatment of diabetes |
| 08/30/2001 | WO2001062228A1 Method for transdermal or intradermal delivery of molecules |
| 08/30/2001 | WO2001062086A1 Nutritional intervention composition for enhancing and extending satiety |
| 08/30/2001 | WO2001025400A3 Compositions and methods for modulating atp-binding cassette transmembrane reporter protein expression |
| 08/30/2001 | WO2001025248A3 Design of high affinity rnase h recruiting oligonucleotide |
| 08/30/2001 | WO2001024842A3 Hybrid matrices and hybrid matrix mixtures |
| 08/30/2001 | WO2001023568A3 Members of the iap gene family |
| 08/30/2001 | WO2001023420A3 Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use |
| 08/30/2001 | WO2001013031A3 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 08/30/2001 | WO2001012806A3 Odorant-binding human proteins fixing hydrophobic ligands: polypeptides and polynucleotides coding for said polypeptides and uses thereof |
| 08/30/2001 | WO2001012776A3 18 human secreted proteins |
| 08/30/2001 | WO2001012658A3 Human icos ligand and application thereof |
| 08/30/2001 | WO2001012236A3 Methods, compositions and kits for promoting recovery from damage to the central nervous system |
| 08/30/2001 | WO2001012127A3 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR |
| 08/30/2001 | WO2001010900A3 Globular assembly of amyloid beta protein and uses thereof |
| 08/30/2001 | WO2001010457A3 Pharmaceutical compositions containing tripeptides |
| 08/30/2001 | WO2001009325A3 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations |
| 08/30/2001 | WO2001009174A3 Plant defensin variants |
| 08/30/2001 | WO2001008696A3 Combined use of interleukin 10 and methotrexate for immuno-modulatory therapy |